谷红注射液对急性脑梗死40例临床评价

Guhong Injection for Treating Acute Cerebral Infarction in 40 Cases

目的观察谷红注射液对急性脑梗死的临床疗效。方法将80例急性脑梗死患者随机分为治疗组与对照组,各40例。两组患者均给予基础治疗,包括抗血小板聚集、降压、调脂、控制血糖等,治疗组患者加用谷红注射液20 mL加入0.9%氯化钠注射液250 mL中静脉滴注,每日1次,连用14 d。观察治疗前及治疗后14 d美国国立卫生院卒中量表(NIHSS)评分、Glasgow昏迷(GCS)评分、血液流变学指标及90 d改良Rankin量表(MRS)评分。结果治疗组患者NIHSS评分、GCS评分、血液流变学指标及90 d MRS评分明显优于对照组(P<0.05)。结论谷红注射液对急性脑梗死有显著临床疗效。

Objective To observe the clinical efficacy of Guhong Injection in treating acute cerebral infarction.M ethods 80 cases of patients with acute cerebral infarction were randomly divided into the treatment group and the control group,40 cases in each group.The two groups were given basic treatment including anti- platelet aggregation,anti- hypertension,lipid- lowering,control of blood glucose.On this basis,the treatment group was added with Guhong Injection 20 mL dissolved in 0.9%sodium chloride injection 250 mL intravenously,1 time per day for 14 d.The NIHSS score,Glasgow coma score,index of hemorheology,90 d modified Rankin scale（MRS） score were observed before and after 14 d treatment.Results The NIHSS score,Glasgow coma score,index of hemorheology,and 90 d MRS score in the treatment group were better than those in the control group（P 0.05）.Conclusions Guhong Injection in treating acute cerebral infarction has clear and remarkably clinical effect.